Logo image of IBN

ICICI BANK LTD-SPON ADR (IBN) Stock Fundamental Analysis

NYSE:IBN - New York Stock Exchange, Inc. - US45104G1040 - ADR

27.53  -0.09 (-0.33%)

Fundamental Rating

4

IBN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 405 industry peers in the Banks industry. There are concerns on the financial health of IBN while its profitability can be described as average. IBN is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IBN had positive earnings in the past year.
In the past year IBN had a positive cash flow from operations.
Each year in the past 5 years IBN has been profitable.
IBN had a positive operating cash flow in 4 of the past 5 years.
IBN Yearly Net Income VS EBIT VS OCF VS FCFIBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500B 1T 1.5T

1.2 Ratios

IBN has a Return On Assets of 1.88%. This is amongst the best in the industry. IBN outperforms 95.23% of its industry peers.
IBN has a better Return On Equity (16.91%) than 95.73% of its industry peers.
Industry RankSector Rank
ROA 1.88%
ROE 16.91%
ROIC N/A
ROA(3y)1.68%
ROA(5y)1.38%
ROE(3y)15.65%
ROE(5y)13.28%
ROIC(3y)N/A
ROIC(5y)N/A
IBN Yearly ROA, ROE, ROICIBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IBN has a better Profit Margin (25.79%) than 67.84% of its industry peers.
IBN's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for IBN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 25.79%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.83%
PM growth 5Y42.71%
GM growth 3YN/A
GM growth 5YN/A
IBN Yearly Profit, Operating, Gross MarginsIBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

3

2. Health

2.1 Basic Checks

IBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IBN has more shares outstanding
The number of shares outstanding for IBN has been increased compared to 5 years ago.
The debt/assets ratio for IBN has been reduced compared to a year ago.
IBN Yearly Shares OutstandingIBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
IBN Yearly Total Debt VS Total AssetsIBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5T 10T 15T 20T

2.2 Solvency

The Debt to FCF ratio of IBN is 1.11, which is an excellent value as it means it would take IBN, only 1.11 years of fcf income to pay off all of its debts.
IBN has a Debt to FCF ratio of 1.11. This is in the better half of the industry: IBN outperforms 76.63% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that IBN is somewhat dependend on debt financing.
IBN has a worse Debt to Equity ratio (0.78) than 83.92% of its industry peers.
Although IBN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 1.11
Altman-Z N/A
ROIC/WACCN/A
WACC8.58%
IBN Yearly LT Debt VS Equity VS FCFIBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500B 1T 1.5T 2T 2.5T

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
IBN Yearly Current Assets VS Current LiabilitesIBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

7

3. Growth

3.1 Past

IBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.78%, which is quite good.
The Earnings Per Share has been growing by 61.93% on average over the past years. This is a very strong growth
IBN shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.93%.
IBN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.94% yearly.
EPS 1Y (TTM)16.78%
EPS 3Y34.49%
EPS 5Y61.93%
EPS Q2Q%13.89%
Revenue 1Y (TTM)22.93%
Revenue growth 3Y10.91%
Revenue growth 5Y11.94%
Sales Q2Q%9.5%

3.2 Future

Based on estimates for the next years, IBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.65% on average per year.
IBN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.80% yearly.
EPS Next Y14.78%
EPS Next 2Y13.21%
EPS Next 3Y13.65%
EPS Next 5YN/A
Revenue Next Year12.99%
Revenue Next 2Y13.25%
Revenue Next 3Y13.8%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IBN Yearly Revenue VS EstimatesIBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500B 1T 1.5T
IBN Yearly EPS VS EstimatesIBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.12, IBN is valued on the expensive side.
Based on the Price/Earnings ratio, IBN is valued a bit more expensive than the industry average as 75.88% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 28.29. IBN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 15.97, IBN is valued correctly.
Based on the Price/Forward Earnings ratio, IBN is valued a bit more expensive than 71.11% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.44. IBN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.12
Fwd PE 15.97
IBN Price Earnings VS Forward Price EarningsIBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

IBN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IBN is cheaper than 92.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.24
EV/EBITDA N/A
IBN Per share dataIBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as IBN's earnings are expected to grow with 13.65% in the coming years.
PEG (NY)1.29
PEG (5Y)0.31
EPS Next 2Y13.21%
EPS Next 3Y13.65%

3

5. Dividend

5.1 Amount

IBN has a yearly dividend return of 0.81%, which is pretty low.
With a Dividend Yield of 0.81, IBN pays less dividend than the industry average, which is at 3.22. 82.16% of the companies listed in the same industry pay a better dividend than IBN!
Compared to an average S&P500 Dividend Yield of 2.28, IBN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.81%

5.2 History

The dividend of IBN is nicely growing with an annual growth rate of 34.51%!
IBN has been paying a dividend for at least 10 years, so it has a reliable track record.
IBN has decreased its dividend recently.
Dividend Growth(5Y)34.51%
Div Incr Years1
Div Non Decr Years1
IBN Yearly Dividends per shareIBN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 50 100 150 200

5.3 Sustainability

14.87% of the earnings are spent on dividend by IBN. This is a low number and sustainable payout ratio.
IBN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP14.87%
EPS Next 2Y13.21%
EPS Next 3Y13.65%
IBN Yearly Income VS Free CF VS DividendIBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500B 1T 1.5T
IBN Dividend Payout.IBN Dividend Payout, showing the Payout Ratio.IBN Dividend Payout.PayoutRetained Earnings

ICICI BANK LTD-SPON ADR

NYSE:IBN (1/22/2025, 11:40:41 AM)

27.53

-0.09 (-0.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-18 2025-01-18
Earnings (Next)N/A N/A
Inst Owners54.36%
Inst Owner Change-0.21%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap97.17B
Analysts87.73
Price Target35.15 (27.68%)
Short Float %0.7%
Short Ratio5.81
Dividend
Industry RankSector Rank
Dividend Yield 0.81%
Yearly Dividend8
Dividend Growth(5Y)34.51%
DP14.87%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.14%
Min EPS beat(2)3.55%
Max EPS beat(2)4.73%
EPS beat(4)4
Avg EPS beat(4)3.81%
Min EPS beat(4)2.68%
Max EPS beat(4)4.73%
EPS beat(8)6
Avg EPS beat(8)2.52%
EPS beat(12)8
Avg EPS beat(12)2.02%
EPS beat(16)10
Avg EPS beat(16)1.29%
Revenue beat(2)0
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-4.62%
Max Revenue beat(2)-1.11%
Revenue beat(4)1
Avg Revenue beat(4)6.64%
Min Revenue beat(4)-4.62%
Max Revenue beat(4)32.9%
Revenue beat(8)4
Avg Revenue beat(8)34.19%
Revenue beat(12)8
Avg Revenue beat(12)67.11%
Revenue beat(16)12
Avg Revenue beat(16)95.75%
PT rev (1m)0.63%
PT rev (3m)3.82%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)1.44%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)1.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.4%
Revenue NY rev (1m)1.03%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 19.12
Fwd PE 15.97
P/S 4.58
P/FCF 4.24
P/OCF 4.15
P/B 3
P/tB 3.04
EV/EBITDA N/A
EPS(TTM)1.44
EY5.23%
EPS(NY)1.72
Fwd EY6.26%
FCF(TTM)6.49
FCFY23.57%
OCF(TTM)6.64
OCFY24.12%
SpS6.01
BVpS9.16
TBVpS9.07
PEG (NY)1.29
PEG (5Y)0.31
Profitability
Industry RankSector Rank
ROA 1.88%
ROE 16.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25.79%
GM N/A
FCFM 107.99%
ROA(3y)1.68%
ROA(5y)1.38%
ROE(3y)15.65%
ROE(5y)13.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.83%
PM growth 5Y42.71%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 1.11
Debt/EBITDA N/A
Cap/Depr 178.4%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 418.79%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)153.33%
Cap/Depr(5y)142.3%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.78%
EPS 3Y34.49%
EPS 5Y61.93%
EPS Q2Q%13.89%
EPS Next Y14.78%
EPS Next 2Y13.21%
EPS Next 3Y13.65%
EPS Next 5YN/A
Revenue 1Y (TTM)22.93%
Revenue growth 3Y10.91%
Revenue growth 5Y11.94%
Sales Q2Q%9.5%
Revenue Next Year12.99%
Revenue Next 2Y13.25%
Revenue Next 3Y13.8%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1050.95%
FCF growth 3Y4.23%
FCF growth 5Y26.57%
OCF growth 1Y1177.87%
OCF growth 3Y4.62%
OCF growth 5Y26.56%